Glaxosmithkline | Salg

Created with Highcharts 10.1.0Chart context menu


Sales Endring Dato
AbbVie USD 15.1B 642M 2024-12
Amgen USD 9.09B 583M 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bausch Health Companies USD 2.56B 50M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 181.89M 656K 2024-12
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
Glaxosmithkline GBP 8.12B 105M 2024-12
Indivior 298M 9M 2024-12
J&J USD 22.52B 49M 2024-12
Merck USD 15.62B 1.03B 2024-12
Novartis USD 13.15B 330M 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Pfizer USD 17.76B 61M 2024-12
Prestige Brands USD 290.32M 6.53M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
Takeda JPY 1.14T 40B 2024-12
Teva Pharmaceutical Industries USD 15.33B 11B 2024-12
Zoetis USD 2.32B 71M 2024-12



Glaxosmithkline Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.